Global First Approval For Daiichi’s EZH1/2 Inhibitor Valemetostat In Japan

Ozoralizumab Also Gets First Nod

 
• By Lisa Takagi
  
The First dual inhibitor for EZH 1/2 approved for ATL
First dual inhibitor for EZH 1/2 approved for ATL • Source: Shutterstock

More from Japan

More from Focus On Asia